| Fund Raise Size | ₹1,000 CrMax target |
|---|---|
| Market Cap | ₹16,780.4 CrMid-cap |
| Revenue TTM | ₹9,013 CrOperating income |
| RSI | 40.6Neutral zone |
Key highlights
- Board approved an aggregate fund raise of up to ₹1,000 crore
- Instruments include equity shares, QIP, ADR/GDR, and convertible debentures
- Provision made for composite issues of non-convertible debentures and warrants
- Capital intended for long-term growth initiatives and strategic capacity expansion
- Board meeting concluded at 5:00 p.m. following the approval on October 1, 2026
What Is the Fund Raise?
Aarti Industries Limited has secured board approval for an enabling resolution to raise funds up to ₹1,000 crore. The capital can be raised through various routes, including Qualified Institutions Placement (QIP), private placement, public issues, or preferential allotments. The instruments permitted under this resolution encompass equity shares, fully or partly convertible debentures, and composite issues of non-convertible debentures with warrants.
This flexible mandate allows the company to choose the most appropriate mode or combination of modes based on market conditions and regulatory approvals. The board meeting for this approval was conducted on October 1, 2026.
Strategic Rationale
The fund raise follows a period of significant capital investment for the company. Aarti Industries is currently focused on its Zone IV expansion and the development of the chlorotoluene value chain, with management previously guiding for an FY27 capital expenditure in the range of ₹700–800 crore. By securing this ₹1,000 crore enabling resolution, the company gains the financial flexibility required to fund these high-value specialty chemical platforms.
This capital buffer is particularly relevant as the company navigates a period of higher working capital needs driven by global supply chain dynamics and efforts to scale up production utilization across its 16 manufacturing facilities.
Business Overview
- Operates a globally recognized specialty chemicals portfolio across benzene and toluene value chains
- Maintains a diversified presence in agrochemicals, pharmaceuticals, polymers, additives, and dyes
- Serves over 1,100 domestic and international customers across more than 60 countries
- Manages 16 manufacturing plants strategically located in Gujarat and Maharashtra
- Recognized for sustainability leadership with an EcoVadis Platinum Rating achieved in 2026
Financial Context
Aarti Industries reported a trailing twelve-month (TTM) operating revenue of ₹9,013 crore and a net profit of ₹531 crore. The company’s balance sheet as of March 2026 reflected a total debt of approximately ₹4,921 crore, placing the debt-to-equity ratio at 0.74. While the company achieved a volume growth rate exceeding 30% in the previous fiscal year, margins have faced pressure from competitive intensity and raw material costs.
The proposed fund raise aims to support the company’s capital allocation strategy while maintaining liquidity as it ramps up new capacities and works toward long-term deleveraging goals.
| Share price | ₹462.6 |
|---|---|
| Market capitalisation | ₹16,780.42 Cr |
| Revenue (annual) | ₹8,286.10 Cr |
| Net profit (annual) | ₹419.06 |
| P/E (TTM) | 31.6×Sector 36.45× |
| Promoter holding | 41.82%-0.27% QoQ |
| FII holding | 7%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Board meeting outcome filing by Aarti Industries Limited announcing a fund raise proposal via an enabling resolution. Market figures from a third-party data provider.
Track Aarti Industries live
Get the next Aarti Industries filing on Telegram seconds after it lands. 15 days free.
